The Therapeutic Role of Monocytes in Alzheimer's Disease: Effects on Vascular Amyloid‐Beta Transport
These findings highlight NOD2 as a promising therapeutic target for modulating innate immune responses to enhance AB clearance. Additionally, the combination of NOD2 activation and glucocorticoids offers a novel dual approach to AD and CAA treatments by promoting both immune and BBB-mediated clearance of AB while reducing inflammation.
Authors
- Nataly Laflamme
- Ayanna Arneaud
- Serge Rivest
Institutions
- Université Laval (CA)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_101318
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00